Gilead Sciences (GILD) Non-Current Assets (2009 - 2026)

Gilead Sciences (GILD) has reported Non-Current Assets for 18 consecutive years, with $35.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 13.62% year-over-year to $35.4 billion; the trailing twelve-month figure through Jun 2026 stood at $154.4 billion (down 3.57% YoY), and the FY2025 full-year result was $40.7 billion, up 2.16% from the prior year.
• Non-Current Assets fell to $35.4 billion in Q2 2026 per GILD's latest filing, from $37.6 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $50.5 billion in Q1 2022 and bottomed at $35.4 billion in Q2 2026.
• Historically, Non-Current Assets has averaged $43.6 billion across 5 years, with a median of $41.8 billion in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets decreased 14.33% in 2024, then advanced 2.3% in 2025.
• Over 5 years, Non-Current Assets stood at $48.7 billion in 2022, then retreated by 5.52% to $46.0 billion in 2023, then retreated by 13.51% to $39.8 billion in 2024, then rose by 2.16% to $40.7 billion in 2025, then slipped by 12.94% to $35.4 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $35.4 billion, $37.6 billion, and $40.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.